Pregled bibliografske jedinice broj: 1145211
Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management
Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management // World journal of gastroenterology, 26 (2020), 21; 2740-2757 doi:10.3748/wjg.v26.i21.2740 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1145211 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and
management
(Post-transplant diabetes mellitus and preexisting
liver disease - a bidirectional relationship
affecting treatment and management)
Autori
Cigrovski Berković, Maja ; Virović-Jukić, Lucija ; Bilić-Ćurčić, Ines ; Mrzljak, Anna
Izvornik
World journal of gastroenterology (1007-9327) 26
(2020), 21;
2740-2757
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
diabetes mellitus ; liver transplantation ; non-alcoholic fatty liver disease ; metabolic syndrome ; insulin-resistance ; glucagon-like peptide-1 receptor agonists ; sodium-glucose cotransporter 2 inhibitors
Sažetak
Liver cirrhosis and diabetes mellitus (DM) are both common conditions with significant socioeconomic burden and impact on morbidity and mortality. A bidirectional relationship exists between DM and liver cirrhosis regarding both etiology and disease-related complications. Type 2 DM (T2DM) is a well recognized risk factor for chronic liver disease and vice-versa, DM may develop as a complication of cirrhosis, irrespective of its etiology. Liver transplantation (LT) represents an important treatment option for patients with end-stage liver disease due to non- alcoholic fatty liver disease (NAFLD), which represents a hepatic manifestation of metabolic syndrome and a common complication of T2DM. The metabolic risk factors including immunosuppressive drugs, can contribute to persistent or de novo development of DM and NAFLD after LT. T2DM, obesity, cardiovascular morbidities and renal impairment, frequently associated with metabolic syndrome and NAFLD, may have negative impact on short and long-term outcomes following LT. The treatment of DM in the context of chronic liver disease and post- transplant is challenging, but new emerging therapies such as glucagon-like peptide-1 receptor agonists (GLP- 1RAs) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) targeting multiple mechanisms in the shared pathophysiology of disorders such as oxidative stress and chronic inflammation are a promising tool in future patient management.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Kineziološki fakultet, Zagreb,
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
KBC "Sestre Milosrdnice",
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek
Profili:
Maja Cigrovski Berković
(autor)
Anna Mrzljak
(autor)
Lucija Virović Jukić
(autor)
Ines Bilić-Ćurčić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE